Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21.81	22.59	32.15	24.65	16.51	14.03
Short-Term Investments	21.54	27.94	37.07	70.32	18.06	11.13
Cash & Cash Equivalents	43.35	50.54	69.23	94.97	34.57	25.16
Cash Growth	-29.05%	-27.00%	-27.11%	174.69%	37.43%	-41.57%
Other Current Assets	4.21	3.39	2.65	1.21	0.76	0.82
Total Current Assets	47.56	53.92	71.88	96.18	35.33	25.97
Property, Plant & Equipment	0.15	0.18	0.3	0.06	0.06	0.1
Goodwill and Intangibles	0.25	0.26	0.33	0	0	0
Other Long-Term Assets	0.29	0.33	0.53	0.76	0.61	1.08
Total Long-Term Assets	0.68	0.77	1.16	0.83	0.67	1.18
Total Assets	48.24	54.69	73.03	97.01	36	27.15
Accounts Payable	1.26	2.42	2.66	1.93	1.02	1.49
Other Current Liabilities	4.07	4.17	3.73	2.59	2.49	4.49
Total Current Liabilities	5.33	6.59	6.38	4.52	3.51	5.98
Other Long-Term Liabilities	0.16	0.21	0.33	0.49	0.25	0.62
Total Long-Term Liabilities	0.16	0.21	0.33	0.49	0.25	0.62
Total Liabilities	5.5	6.8	6.71	5.01	3.76	6.6
Retained Earnings	-533.48	-528.08	-507.24	-453.02	-425.55	-417.4
Comprehensive Income	-0.1	-0.04	-0.03	-0.07	-0.01	0
Shareholders' Equity	43	48.15	66.58	92.25	32.5	20.82
Net Cash / Debt	43.35	50.54	69.23	94.97	34.57	25.16
Net Cash / Debt Growth	-29.05%	-27.00%	-27.11%	174.69%	37.43%	-41.57%
Net Cash Per Share	5.23	6.26	13.36	25.75	33.59	36.55
Working Capital	42.23	47.33	65.49	91.66	31.83	20
Book Value Per Share	5.18	5.96	12.85	25.02	31.57	30.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).